Delivery Order SPE2DB20D3303-SPE2DB24FA0XE
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $3,113.28, is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is a delivery order valued at $1,556.64. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Micardis HCT 80-25 mg tablets. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The contract has a ceiling value of $1,920.22 and a period of performance through June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a Delivery Order valued at $2,000.11 for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of November 8, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating the contract was awarded through full and open competition. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,762.64 and is a firm fixed-price delivery order that runs through May 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,867.08 Firm Fixed Price Delivery Order is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S. The contract has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Micardis HCT 40-12.5 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,765.24, has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,632.91, has a completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,003.44 Firm Fixed Price Delivery Order is for the provision of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order with a ceiling value of $2,098.93. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and is for the supply of the pharmaceutical product Micardis HCT 80-12.5 mg tablet. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...